课题基金 / 基金详情

ALTERED NITRIC OXIDE MECHANISMS IN PVN DURING DIABETES

ALTERED NITRIC OXIDE MECHANISMS IN PVN DURING DIABETES
糖尿病期间 PVN 中一氧化氮机制的改变
批准号:
6529415
负责人:
KAUSHIK P PATEL
金额:
$21.64万
依托单位国家:
美国
项目类别:
财政年份:
1999
资助国家:
美国
项目状态:
已结题
起止时间:
1999-09-30 至 2005-08-31

项目摘要

项目成果

KAUSHIK P PATEL的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Patients with insulin dependent diabetes mellitus (IDDM) and all animals models of IDDM exhibit altered autonomic regulation. This abnormality increases the risk of mortality during diabetes. The central mechanisms which underlie these abnormalities are poorly understood. We have recently obtained data which suggest that the paraventricular nucleus (PVN), a central site known to receive afferent information from various visceral afferents and to alter sympathetic outflow, may contribute to altered autonomic outflow during the diabetic state. Furthermore, altered nitric oxide (NO) and gamma-amino butyric acid (GABA) mechanisms within the PVN may be involved in this autonomic outflow. This proposal tests the hypothesis that disrupted NO and GABA mechanisms within the PVN contribute to the altered sympathetic outflow during IDDM. We propose to: first, determine if NO mechanisms are altered in rats with IDDM; second, determine if NO mechanisms within the PVN contributes to the altered sympathetic nerve activity in rats with IDDM; third determine if GABA mechanisms within the PVN contributes to the altered sympathetic nerve activity in rats with IDDM; and fourth, determine if there is altered interaction of NO and GABA mechanisms within the PVN in rats with IDDM. It is anticipated that NO and GABA mechanisms within the PVN contribute to the altered autonomic outflow commonly observed during IDDM. The results should provide significant new information regarding central mechanisms of altered sympatho-excitations specifically involvement of the NO and GABA systems within the PVN, in the altered sympathetic neural activation in the diabetic state. Understanding the role of the central mechanisms, not studied to date, in the altered sympathetic neural drive would enhance our ability to treat the diabetic condition and its cardiovascular complications.
期刊论文(7)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1016/j.bcp.2010.03.024
发表时间: 2010-07-15
期刊: BIOCHEMICAL PHARMACOLOGY
影响因子: 5.8
作者: [Shao, Chun-Hong, Rozanski, George J., Nagai, Ryoji, Stockdale, Frank E., Patel, Kaushik P., Wang, Mu, Singh, Jaipaul, Mayhan, William G., Bidasee, Keshore R.]
通讯作者: Bidasee, Keshore R.
DOI: 10.2337/db10-1145
发表时间: 2011-03
期刊: Diabetes
影响因子: 7.7
作者: [Shao CH, Capek HL, Patel KP, Wang M, Tang K, DeSouza C, Nagai R, Mayhan W, Periasamy M, Bidasee KR]
通讯作者: Bidasee KR
Blunted nitric oxide-mediated inhibition of sympathetic nerve activity within the paraventricular nucleus in diabetic rats.
糖尿病大鼠室旁核内一氧化氮介导的交感神经活动抑制作用减弱。
DOI: 10.1152/ajpregu.00363.2005
发表时间: 2006
期刊: American journal of physiology. Regulatory, integrative and comparative physiology
影响因子: --
作者: [Zheng,Hong, Mayhan,WilliamG, Bidasee,KeshoreR, Patel,KaushikP]
通讯作者: Patel,KaushikP
Novel target mechanism (renal nerves) for the beneficial actions of SGLT2 inhibition in congestive heart failure
Novel target mechanism (renal nerves) for the beneficial actions of SGLT2 inhibition in congestive heart failure
Novel target mechanism (renal nerves) for the beneficial actions of SGLT2 inhibition in congestive heart failure
Novel Target Mechanism (Renal Denervation) to Reduce Sodium Retention in Chronic Heart Failure
海外基金